Genetic of Intellectual Deficiency and Autism Spectrum Disorders (RaDiCo-GenIDA)

Last updated: March 6, 2025
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Overall Status: Active - Recruiting

Phase

N/A

Condition

Autism

Asperger's Disorder

Autism Spectrum Disorder (Asd)

Treatment

N/A

Clinical Study ID

NCT06871696
C14-35
  • Ages > 18
  • All Genders

Study Summary

The aim of this observational study is to develop an alternative database model for genetically originated intellectual disabilities. This model will take the form of an online cohort study, where the majority of clinical information will be provided by the families of the patients. Questionnaires developed by professionals but formulated in a way understandable to families will be used to gather this information.

Specifically, this study aims to collect relevant information for personalized medical management. This includes understanding the risks of specific pathological complications and potential iatrogenic effects of symptomatic treatments. The primary goal is to establish groups of individuals with intellectual disabilities and/or autism spectrum disorders (ASD) sharing the same genetic mutation. This approach will provide a better understanding of the natural history of the disease and associated comorbidities.

It is important to note that this project will only focus on patients for whom the identification of the causal mutation or penetrant copy number variation (CNV) has been determined. It excludes individuals for whom the cause of intellectual disability is unknown.

This approach will contribute to a better understanding of the genetic aspects of intellectual disabilities and ASD, while facilitating more targeted and personalized medical care for the affected patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Be a voluntary adult (aged 18 or older)

  • Be a family member (i.e., mother/father) of patients with intellectual disabilitiesand/or autism spectrum disorders of known genetic origin. This includes monogeniccauses as well as recurrent copy number variations (CNVs) such as deletions orduplications. Note: we also allow adult patients to participate directly if theywish and have the capacity to do so.

  • Have knowledge of the genetic cause behind intellectual disabilities or autismspectrum disorders. An exception to this rule is possible for patients with asyndrome that includes intellectual disabilities or autism spectrum disorders, andfor whom genetic investigation is considered, with the approval of the project'sscientific council (which will define the syndromes eligible for this exception).

  • Have the intellectual and material capabilities to complete an internetquestionnaire.

  • Have read the information sheet regarding the study and agreed to the generalconditions of participation in the study.

There are no restrictions based on age, gender, or potential comorbidities of the individual themselves.

Exclusion

Exclusion Criteria:

  • Patients affected by the presence of intellectual disability and/or an autismspectrum disorder of unknown genetic origin will not be able to participate in thestudy, except with the exception mentioned in the previous chapter.

  • It is requested that only adults enter data. However, the collected data may pertainto a minor (in the case of a parent entering data about their minor child)

Study Design

Total Participants: 1000
Study Start date:
November 01, 2016
Estimated Completion Date:
November 30, 2026

Connect with a study center

  • RaDiCo-GenIDA

    Paris, Île-de-France 75012
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.